Indeed, after binding to HER2, the Fc portion of TZ antibody stimulates the antitumor immunity and the cytotoxic activity of natural killer cells, which recognize TZ-coated breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.